266 related articles for article (PubMed ID: 31760675)
1. Guillain-Barré syndrome: clinical features, treatment choices and outcomes in an Australian cohort.
Barnes SL; Herkes GK
Intern Med J; 2020 Dec; 50(12):1500-1504. PubMed ID: 31760675
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome: clinical profile and management.
Sudulagunta SR; Sodalagunta MB; Sepehrar M; Khorram H; Bangalore Raja SK; Kothandapani S; Noroozpour Z; Aheta Sham M; Prasad N; Sunny SP; Mohammed MD; Gangadharappa R; Nidsale Sudarshan R
Ger Med Sci; 2015; 13():Doc16. PubMed ID: 26421004
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
Alanazy MH; Bakry SS; Alqahtani A; AlAkeel NS; Alazwary N; Osman AM; Mustafa RA; Al-Harbi TM; Abdulmana SO; Amper AC; Aldughaythir Y; Ali AS; Makkawi S; Maglan A; Alamoudi L; Alsulaiman F; Alabdali M; AlShareef AA; Abuzinadah AR; Bamaga AK
BMC Neurol; 2021 Jul; 21(1):275. PubMed ID: 34253174
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Treatment Outcome and Clinical Profile among Guillain- Barre Syndrome Patients in South India.
Joseph N; Shrigiri S
Rev Recent Clin Trials; 2023; 18(4):258-268. PubMed ID: 37907491
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.
I Espiritu A; Separa KJNJ; Milla FJC; Adiao KJB; Leochico CFD; Jamora RDG
Neurol Res; 2021 Dec; 43(12):995-1004. PubMed ID: 34229572
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Guillain-Barré Syndrome in Tertiary Care Centers in Thailand.
Kulkantrakorn K; Sukphulloprat P
J Clin Neuromuscul Dis; 2017 Dec; 19(2):51-56. PubMed ID: 29189549
[TBL] [Abstract][Full Text] [Related]
7. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
Verma R; Chaudhari TS; Raut TP; Garg RK
J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2012 Jul; (7):CD002063. PubMed ID: 22786476
[TBL] [Abstract][Full Text] [Related]
9. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
Eur J Neurol; 2023 Dec; 30(12):3646-3674. PubMed ID: 37814552
[TBL] [Abstract][Full Text] [Related]
10. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
J Peripher Nerv Syst; 2023 Dec; 28(4):535-563. PubMed ID: 37814551
[TBL] [Abstract][Full Text] [Related]
11. Functional outcomes following inpatient rehabilitation of Guillain-Barré syndrome patients: Intravenous immunoglobulins versus plasma exchange.
Bondi M; Engel-Haber E; Wolff J; Grosman-Rimon L; Bloch A; Zeilig G
NeuroRehabilitation; 2021; 48(4):543-551. PubMed ID: 34024788
[TBL] [Abstract][Full Text] [Related]
12. The Guillain-Barré syndrome.
Fujimura H
Handb Clin Neurol; 2013; 115():383-402. PubMed ID: 23931791
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
van Doorn PA
Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
[TBL] [Abstract][Full Text] [Related]
14. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
[TBL] [Abstract][Full Text] [Related]
15. Changes in the severity and subtype of Guillain-Barré syndrome admitted to a specialist Neuromedical ICU over a 25 year period.
Taylor CJ; Hirsch NP; Kullmann DM; Howard RS
J Neurol; 2017 Mar; 264(3):564-569. PubMed ID: 28091723
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.
El-Bayoumi MA; El-Refaey AM; Abdelkader AM; El-Assmy MM; Alwakeel AA; El-Tahan HM
Crit Care; 2011 Jul; 15(4):R164. PubMed ID: 21745374
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré syndrome (GBS).
Pithadia AB; Kakadia N
Pharmacol Rep; 2010; 62(2):220-32. PubMed ID: 20508277
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Guillain-Barré syndrome: a review.
Rajabally YA
Inflamm Allergy Drug Targets; 2012 Aug; 11(4):330-4. PubMed ID: 22452606
[TBL] [Abstract][Full Text] [Related]
19. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
Fokke C; van den Berg B; Drenthen J; Walgaard C; van Doorn PA; Jacobs BC
Brain; 2014 Jan; 137(Pt 1):33-43. PubMed ID: 24163275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
